Business
HeartBeam (BEAT) Reports Q4 and Full-Year 2025 Results, Advances Commercialization and Clinical Development
LOS ANGELES, CA - March 13, 2026 (NEWMEDIAWIRE) - HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, reported financial and operational results for the fourth quarter an...
About this update from Heartbeam, Inc.
[{"type":"text","content":"LOS ANGELES, CA - March 13, 2026 (NEWMEDIAWIRE) - HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, reported financial and operational results for the fourth quarter and full year ended Dec. 31, 2025, highlighting progress toward commercialization following U.S. Food and Drug Administration ("FDA") 510(k) clearance of its 12-lead electrocardiogram ("ECG") synthesis software in December 2025. The company has initiated a limited market launch targeting concierge and preventive cardiology groups and secured its first commercial partnership with ClearCardio(TM), while also enrolling initial patients in its ALIGN-ACS pilot study evaluating the HeartBeam System for heart attack detection. Additional developments include completion of a prototype extended-wear 12-lead ECG patch, a strategic collaboration with the Icahn School of Medicine at Mount Sinai to advance AI-enabled ECG algorithms and the appointment of a new chief commercial officer to support growth initiatives.","length":1081,"tagName":"p"},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":"Investor Brand Network","className":"","disableSlideshowImg":false,"size":{"original":{"width":1352,"height":488,"url":"https://media.zenfs.com/en/newsmediawire_165/6e1352d70061daad28d56e4148cf7a07"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/mrl5X1.nMPMZ0DZ0b_zgKQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTM0NztjZj13ZWJw/https://media.zenfs.com/en/newsmediawire_165/6e1352d70061daad28d56e4148cf7a07","width":960,"height":347},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/_MKOQWINtgrpcKF3ElLFLQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD04NjY7Y2Y9d2VicA--/https://media.zenfs.com/en/newsmediawire_165/6e1352d70061daad28d56e4148cf7a07","width":1200,"height":433}}},{"type":"text","content":"To view the full press release, visit https://ibn.fm/3KQqG","length":58,"tagName":"p"},{"type":"text","content":"About HeartBeam, Inc.","length":21,"tagName":"p"},{"type":"text","content":"HeartBeam, Inc. is a medical technology company dedicated to transforming the detection and monitoring of critical cardiac conditions. The Company is creating the first-ever cable-free device capable of collecting ECG signals in 3D, from three non-coplanar directions, and synthesizing the si...